Omaha-Based MRI Medical Device Company, Bot Image, Receives FDA Clearance for AI

Updated: Aug 23

FOR IMMEDIATE RELEASE

Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx). The tool, called ProstatID(TM), combines artificial intelligence with traditional MRI scanning.

"Prostate cancer screening and detection methods adoption has changed little over the past 30 years, despite the mountain of evidence pointing to the efficacy of superior technologies and the futility of the old methods,” says the company founder and CEO Dr. Randall W. Jones. “Sadly, this has resulted in the unnecessary and premature deaths of countless numbers of men in the US alone. ProstatID represents an exciting step in the fight to save lives.”

READ FULL PRESS RELEASE

BotImagePressRelease-FDAClearance8-4-22
.pdf
Download PDF • 566KB

90 views0 comments